Global Nucleic Acid Isolation and Purification Market – Industry Trends and Forecast to 2031

Nucleic Acid Isolation and Purification Market Analysis and Size

The global nucleic acid isolation and purification market is experiencing significant growth, driven by the expanding applications of nucleic acids in research, diagnostics, and therapeutics. Advances in genomics and molecular biology have increased the demand for high-quality nucleic acid isolation and purification techniques, which are crucial for accurate sequencing, gene expression analysis, and genetic testing. The rise in personalized medicine and the growing prevalence of genetic disorders are further fueling market growth, as these techniques are essential for developing targeted treatments and diagnostic tools. In addition, the increasing adoption of next-generation sequencing (NGS) technologies and the growing focus on research and development in the biotechnology and pharmaceutical industries are contributing to the market's expansion.

Global nucleic acid isolation and purification market size was valued at USD 3.10 billion in 2023 and is projected to reach USD 8.24 billion by 2031, with a CAGR of 13.00% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation       

Market Definition

Nucleic acid isolation and purification refer to the processes used to extract and purify nucleic acids, such as DNA and RNA, from biological samples for further analysis and experimentation. These techniques are crucial in molecular biology, genomics, and clinical diagnostics, as they provide the high-quality nucleic acids needed for accurate and reliable results in various applications.                 

Nucleic Acid Isolation and Purification Market Dynamics

Drivers     

• Growing Demand for Precision Medicine   

As healthcare shifts towards treatments tailored to individual genetic profiles, the accuracy and reliability of nucleic acid extraction become crucial. Precision medicine aims to customize healthcare by analyzing genetic, environmental, and lifestyle factors to provide targeted therapies. This approach necessitates precise and contaminant-free nucleic acid samples to ensure accurate genetic analysis and successful treatment outcomes. As a result, the demand for advanced isolation and purification technologies that can deliver high-quality genetic material is increasing, fueling growth in the market for these essential tools.      

• Increasing Prevalence of Chronic and Genetic Disorders      

The rising incidence of chronic diseases and genetic disorders is creating a robust demand for advanced nucleic acid testing and analysis technologies. Chronic conditions such as diabetes, cardiovascular diseases, and cancer, as well as genetic disorders such as cystic fibrosis and muscular dystrophy, require thorough genetic investigation for diagnosis and management. Effective nucleic acid isolation and purification are fundamental for obtaining reliable genetic information necessary for accurate diagnosis, treatment planning, and monitoring of these conditions. The growing prevalence of these disorders amplifies the need for sophisticated technologies that can ensure high-quality nucleic acid samples, thus driving the market for isolation and purification solutions.

Opportunities

• Development of Advanced Purification Technologies 

Researchers and clinicians are constantly seeking solutions that offer greater efficiency, speed, and ease of use to meet their evolving needs. Advancements in technology could lead to the creation of more sophisticated systems capable of handling a broader range of sample types, delivering higher yields, and improving the overall reliability of results. Innovations such as automated workflows, enhanced reagent formulations, and novel extraction methods have the potential to revolutionize the field, making nucleic acid isolation and purification more accessible and efficient. As the demand for precision and high-throughput solutions increases, the development of these advanced technologies represents a significant opportunity for growth and differentiation in the market.        

• Rising Investments in Biotechnology and Research  

Increased financial support allows researchers to explore new methodologies, improve existing technologies, and develop high-throughput solutions that address current limitations in the field. This influx of capital not only accelerates technological innovation but also fosters the growth of new market players and enhances the competitive landscape. As biotechnology continues to advance, the demand for more efficient and scalable nucleic acid isolation and purification solutions grows, further supported by the ongoing investment in research and development. This trend underscores the critical role of financial backing in driving progress and expanding the capabilities of nucleic acid technologies.

Restraints/Challenges

• High Costs of Advanced Systems

The high costs associated with advanced nucleic acid isolation and purification systems and reagents present a significant barrier to widespread adoption, especially for smaller research facilities and laboratories with limited budgets. The sophisticated technologies required for efficient nucleic acid extraction and purification involve expensive equipment and specialized reagents, which can be prohibitive for institutions with constrained financial resources. This financial barrier can restrict access to cutting-edge technologies and hinder the ability of smaller labs to compete in the rapidly evolving field of genomics and molecular biology. 

• Complexity of Sample Types

The variability and complexity of sample types can significantly impact the efficiency and reproducibility of nucleic acid isolation and purification processes. Different biological samples, such as blood, tissue, or saliva, can present unique challenges in terms of composition and quality, affecting the performance of isolation methods. This variability can lead to inconsistencies in yield and purity, making it difficult to standardize procedures and ensure reliable results across different samples and experiments.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In April 2024, New England Biolabs introduced its Monarch Mag Viral DNA/RNA Extraction Kit, designed to improve the recovery of low quantities of viral nucleic acids for highly sensitive detection. This kit utilizes a magnetic bead-based method for the reproducible and efficient extraction of viral RNA and DNA, with capabilities for scaling up to high-throughput automation. It is compatible with a range of sample types, including saliva, respiratory swabs, and, after an enrichment step, wastewater samples
• In December 2023, Alfa Chemistry, a trusted chemical supplier and innovative provider of research reagents and materials, announced the launch of a wide selection of biological reagents for use in nucleic acid purification systems. These new offerings provided researchers with efficient and reliable tools to isolate and purify various types of nucleic acids, including plasmid DNA, PCR products, genomic DNA, RNA, and viral nucleic acids

Nucleic Acid Isolation and Purification Market Scope

The market is segmented on the basis of product, methods, type, application, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

• Column-based Purification
• Magnetic Bead-based Purification
• Reagent-based Purification

Product

• Kits and Reagents
• Equipment
• Other Products

Application

• Total RNA Isolation and Purification
• mRNA Isolation and Purification
• microRNA Isolation and Purification
• Plasmid DNA Isolation and Purification
• Genomic DNA Isolation and Purification
• Blood DNA Isolation and Purification
• PCR Clean-up
• Other Nucleic Acid Isolation and Purification Applications

End User

• Hospitals
• Academic and Research Institutes
• Pharmaceutical/Biotechnology Industry
• Other

Nucleic Acid Isolation and Purification Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, product, methods, type, application, and end user as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

North America is expected to dominate the market due to substantial research and development (R&D) investments by biotechnology and pharmaceutical companies, advanced technological infrastructure and strong government support for scientific research, which collectively foster continued innovation and development in this field.

Asia-Pacific is expected to witness significant growth during the forecast period due to an increasing number of genomic projects and a surge in research and development activities within the region. The expansion of genomic research, coupled with rising investments from pharmaceutical and biotechnology firms, is expected to further propel the market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Nucleic Acid Isolation and Purification Market Share Analysis

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Some of the major players operating in the market are:

• Thermo Fisher Scientific Inc. (US)
• QIAGEN (Germany)
• Merck KGaA (Germany)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Promega Corporation (US)
• Agilent Technologies, Inc. (US)
• Danaher (US)
• Bio-Rad Laboratories, Inc. (US)
• Illumina, Inc. (US)
• Takara Bio Inc. (Japan)
• New England Biolabs (US)
• Abcam Plc (UK)
• KILPEST India Limited (India)
• Apical Scientific Sdn. Bhd. (Malaysia)
• Endress+Hauser Group Services AG (Switzerland)
• GENAXXON Bioscience GmbH (Germany)
• LGC Biosearch Technologies (US)
• Zymo Research Corporation (US)
• Norgen Biotek Corp. (Canada)
• Omega Bio-Tek, Inc. (US)
• FAVORGEN Biotech Corp. (China)
• TIANGEN Biotech (Beijing) Co., Ltd. (China)
• AutoGen Inc. (US)
• PCR Biosystems (UK)
• Biogenuix (India)

SKU-14250